|
SGPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.206040E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.966720E-04 |
| Normal-vs-Stage2 |
2.297800E-01 |
| Normal-vs-Stage3 |
3.259800E-03 |
| Normal-vs-Stage4 |
2.157100E-03 |
| Stage1-vs-Stage2 |
2.050200E-01 |
| Stage1-vs-Stage3 |
7.850800E-01 |
| Stage1-vs-Stage4 |
6.740600E-01 |
| Stage2-vs-Stage3 |
3.100400E-01 |
| Stage2-vs-Stage4 |
1.630970E-01 |
| Stage3-vs-Stage4 |
5.432200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.33569999999306E-05 |
| Normal-vs-AfricanAmerican |
1.169560E-02 |
| Normal-vs-Asian |
3.325900E-02 |
| Caucasian-vs-AfricanAmerican |
2.433200E-01 |
| Caucasian-vs-Asian |
6.125800E-01 |
| AfricanAmerican-vs-Asian |
2.072000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.175700E-03 |
| Normal-vs-Female |
1.183900E-04 |
| Male-vs-Female |
5.422400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.048600E-04 |
| Normal-vs-Age(41-60Yrs) |
2.564100E-03 |
| Normal-vs-Age(61-80Yrs) |
7.744000E-03 |
| Normal-vs-Age(81-100Yrs) |
5.060100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.681200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.704600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.333400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.094400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.068600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.388800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.262400E-01 |
| Classical-VS-Follicular |
3.12349999975758E-07 |
| Classical-VS-Other |
2.404800E-01 |
| Classical-VS-Normal |
5.82670000026653E-07 |
| Tall-VS-Follicular |
5.819100E-04 |
| Tall-VS-Other |
1.749360E-01 |
| Tall-VS-Normal |
1.378500E-03 |
| Follicular-VS-Other |
6.156600E-01 |
| Follicular-VS-Normal |
7.531400E-01 |
| Other-VS-Normal |
6.163400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.318300E-02 |
| Normal-vs-N1 |
2.302200E-02 |
| N0-vs-N1 |
4.026600E-01 |
|
|
